ArticleChemistry & biodiversity2026
Valorization of Fish Scale Waste Into Composite Films: Physicochemical, Mechanical, Antibacterial, and HET-CAM Angiogenesis Evaluation.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chitosan extracted from Labeo rohita fish scales via chemical demineralization, deproteinization, and deacetylation yields 25% overall from raw scales. The chitosan has 88%-90% deacetylation, a molecular weight (MW) of 109.5 kDa, and low residual ash (0.1%) and protein (0.29%). Composite films (CGP) with fixed gelatin: polyvinylpyrrolidone (PVP, 10:5) and varying chitosan (1%-7% w/v) are prepared. FTIR confirms cross‑linking; SEM shows smooth surfaces for CGP 3% and CGP 5%, but rougher texture for CGP 7%. Water uptake decreases with higher chitosan content (160% for CGP 1% vs. 22% for CGP 7%). PBS buffer uptake is highest for CGP 1%-5% (80%-120%), and lowest for CGP 7% (∼40%). Lower chitosan content slows degradation. Tensile strength increases with chitosan concentration (27 MPa for CGP 1% to 32.8 MPa for CGP 7%), while elongation at break decreases (13% to 4%). Antibacterial activity against Escherichia coli and Staphylococcus aureus is strongest for CGP 3% and CGP 5% (inhibition zones 13-14 mm), outperforming pure chitosan. In the hen's egg test on the chorioallantoic membrane (HET‑CAM) assay, CGP 3% induces the highest angiogenic response (27.2 ± 0.3 vs. 12.9 ± 0.6 vessels in control), with no toxicity. CGP 3% and CGP 5% are optimal for wound‑healing applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.